CV vs PH · rev $3.5M vs P/E 28, rev $19.85B
CapsoVision, Inc. Common Stock (CV) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
CapsoVision, Inc. Common Stock (CV) is a medical devices company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported CV revenue for 2025-09-30 was $3.5M. Net income was -$7.9M. Revenue was up 6.7% from 2025-06-30 to 2025-09-30. CV currently screens at market cap $359.2M.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
CV currently screens at market cap $359.2M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the CV and PH stock pages for the full models.
Not investment advice.